BlackRock’s Moleculin Biotech MBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.74K Hold
12,380
﹤0.01% 5214
2025
Q1
$12.1K Hold
12,380
﹤0.01% 5115
2024
Q4
$21K Sell
12,380
-95
-0.8% -$162 ﹤0.01% 5038
2024
Q3
$35.4K Hold
12,475
﹤0.01% 4821
2024
Q2
$43.9K Buy
12,475
+2
+0% +$7 ﹤0.01% 4839
2024
Q1
$73.7K Sell
12,473
-122
-1% -$721 ﹤0.01% 4738
2023
Q4
$162K Sell
12,595
-492
-4% -$6.34K ﹤0.01% 4616
2023
Q3
$83.9K Buy
13,087
+7
+0.1% +$45 ﹤0.01% 4829
2023
Q2
$114K Sell
13,080
-4,166
-24% -$36.2K ﹤0.01% 4785
2023
Q1
$248K Buy
17,246
+123
+0.7% +$1.77K ﹤0.01% 4631
2022
Q4
$272K Sell
17,123
-403
-2% -$6.41K ﹤0.01% 4682
2022
Q3
$278K Sell
17,526
-144
-0.8% -$2.28K ﹤0.01% 4804
2022
Q2
$384K Sell
17,670
-18
-0.1% -$391 ﹤0.01% 4769
2022
Q1
$472K Sell
17,688
-604
-3% -$16.1K ﹤0.01% 4796
2021
Q4
$510K Buy
18,292
+265
+1% +$7.39K ﹤0.01% 4791
2021
Q3
$812K Sell
18,027
-456
-2% -$20.5K ﹤0.01% 4549
2021
Q2
$1.02M Buy
18,483
+2,528
+16% +$139K ﹤0.01% 4437
2021
Q1
$977K Buy
15,955
+15,471
+3,196% +$947K ﹤0.01% 4442
2020
Q4
$34K Hold
484
﹤0.01% 4638
2020
Q3
$36K Hold
484
﹤0.01% 4544
2020
Q2
$42K Sell
484
-1,067
-69% -$92.6K ﹤0.01% 4516
2020
Q1
$85K Buy
1,551
+16
+1% +$877 ﹤0.01% 4307
2019
Q4
$127K Buy
1,535
+352
+30% +$29.1K ﹤0.01% 4340
2019
Q3
$118K Sell
1,183
-68
-5% -$6.78K ﹤0.01% 4361
2019
Q2
$141K Buy
1,251
+718
+135% +$80.9K ﹤0.01% 4363
2019
Q1
$39K Sell
533
-36
-6% -$2.63K ﹤0.01% 4460
2018
Q4
$54K Sell
569
-10
-2% -$949 ﹤0.01% 4419
2018
Q3
$83K Buy
579
+23
+4% +$3.3K ﹤0.01% 4418
2018
Q2
$89K Buy
+556
New +$89K ﹤0.01% 4421
2017
Q2
Sell
-199
Closed -$21K 4984
2017
Q1
$21K Buy
+199
New +$21K ﹤0.01% 4546